The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours

To study the prevalence of avascular necrosis in patients receiving chemotherapy for testicular cancer we invited 103 consecutive patients treated by chemotherapy to attend for MRI scan of the hips. Four of 47 (9% (CI 2–20%)) patients scanned and 4/103 (3.8% (CI 1–10%)) of patients invited to partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, A M, Dzik-Jurasz, A S K, Padhani, A R, Norman, A, Huddart, R A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363966/
https://www.ncbi.nlm.nih.gov/pubmed/11742478
http://dx.doi.org/10.1054/bjoc.2001.2155
Descripción
Sumario:To study the prevalence of avascular necrosis in patients receiving chemotherapy for testicular cancer we invited 103 consecutive patients treated by chemotherapy to attend for MRI scan of the hips. Four of 47 (9% (CI 2–20%)) patients scanned and 4/103 (3.8% (CI 1–10%)) of patients invited to participate in the study had evidence of avascular necrosis. As not all patients in the study had completed the at risk period this equates to a 3-year actuarial risk of 6.3% (95% confidence limits (CI) 2.4–16.1). These data suggest that avascular necrosis is an uncommon but significant complication of chemotherapy including steroids as anti-emetics. © 2001 Cancer Research Campaign http://www.bjcancer.com

Ejemplares similares